header advert
Results 1 - 2 of 2
Results per page:
The Bone & Joint Journal
Vol. 103-B, Issue 7 | Pages 1292 - 1300
1 Jul 2021
Märtens N Heinze M Awiszus F Bertrand J Lohmann CH Berth A

Aims

The purpose of this study was to compare clinical results, long-term survival, and complication rates of stemless shoulder prosthesis with stemmed anatomical shoulder prostheses for treatment of osteoarthritis and to analyze radiological bone changes around the implants during follow-up.

Methods

A total of 161 patients treated with either a stemmed or a stemless shoulder arthroplasty for primary osteoarthritis of the shoulder were evaluated with a mean follow-up of 118 months (102 to 158). The Constant score (CS), the Disabilities of the Arm, Shoulder and Hand (DASH) score, and active range of motion (ROM) were recorded. Radiological analysis for bone adaptations was performed by plain radiographs. A Kaplan-Meier survivorship analysis was calculated and complications were noted.


Orthopaedic Proceedings
Vol. 101-B, Issue SUPP_14 | Pages 95 - 95
1 Dec 2019
Meinshausen A Märtens N Illiger S Macor P Färber J Lohmann CH Bertrand J
Full Access

Aim

Low-grade infections cannot be easily distinguished from aseptic complications frequently leading to false negative diagnoses and late onset of anti-bacterial therapy. Therefore, there is a great need to establish biomarkers for early detection of low-grade infections.

Method

In this study, we focused on the investigation of anti-α-defensin, anti-C3, anti-C5 and anti-C9 as potential biomarkers for infection in a cohort of hip and knee septic revision cases, taking patient characteristics and comorbidities into account. Here we included 78 patients with septic (35) and aseptic (43) (woman:37, men:42, age 50 – 93 years) revision surgeries of hip and knee. CRP serum levels and leucocyte blood values were evaluated. Patient characteristics, including age, number of prior revision surgeries and comorbidities were recorded. Periprosthetic tissue was stained histologically with Hematoxylin/Eosin and immunohistologically with different antibodies.